HUMS Hospital

Issues Description:
Currently, the Patient Consumption module does not clearly indicate when a medication is classified as Dangerous Drug Act (DDA) or cytotoxic drug. This may lead to difficulty in identifying high-risk medications during dispensing and administration, increasing the risk of medication errors.

There is no visual indicator or label to differentiate normal medications from controlled substances such as DDA or cytotoxic drugs within the Patient Consumption screen.

Step to reproduce:
1.Login System
2.Navigate to > Pharmacy
3.Click on Patient Consumption
4.Observe screen > the Patient Consumption module does not clearly indicate when a medication is classified as Dangerous Drug Act (DDA) or cytotoxic drug.

Expectation:
The system should display a clear indicator for medications classified as DDA or cytotoxic drugs in the Patient Consumption module.

A visible label or icon (e.g., ⚠️ or badge) should be shown next to the medication name.
The indicator should clearly differentiate DDA and cytotoxic drugs from normal medications.
This information should be visible during dispensing and administration to ensure patient safety and compliance with medication handling guidelines.

Picture 1: The expectation of screen of Patient Consumption with indicator DDA.